SHELTON CAPITAL MANAGEMENT - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$1,009,196
-44.6%
160,700
-7.0%
0.11%
+21.8%
Q3 2022$1,823,000
+84.5%
172,800
-5.1%
0.09%
+97.7%
Q2 2022$988,000
-40.9%
182,0000.0%0.04%
-29.0%
Q1 2022$1,671,000
-39.1%
182,0000.0%0.06%
-36.1%
Q4 2021$2,746,000
-16.6%
182,000
+31.9%
0.10%
-24.8%
Q3 2021$3,294,000138,0000.13%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
View complete list of CARIBOU BIOSCIENCES INC shareholders